Ionis Pharmaceuticals, Inc. (IONS) stock analysis
In our weekly check, Ionis Pharmaceuticals, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 8 pass, warnings: 3, red flags: 11.
About Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as IONS.
What our checks show for IONS
Red flags
- Debt is high against equity (5.47x). That limits room in a downturn.
- The company has an operating loss, so it does not cover the interest bill: interest is paid from cash or new debt.
- The net margin fell by 53.4 points over 5 years, to -56.9%: the company keeps less of each sale as profit.
- Weak EPS forecast
- Weak EPS growth
- The company is losing money: the net margin is -56.9%.
- Free cash flow is negative (-64.2% of revenue): the business spends more cash than it brings in.
- The price swings a lot: 55.6% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 73% from a peak. Would you have held through that?
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
- Recovering from its deepest fall took about 2.7 years.
- The share count grew by 11.9% in 2 years: each shareholder owns a smaller slice.
Strengths
- Analysts expect revenue to grow about 24.5% a year over the next years.
- Analysts expect the net margin to improve by 62.3 points from today's -56.9%.
- Revenue grew 17.8% a year over the last 3 years.
- Beta 0.4: the stock usually moves less than the market.
- Actively traded: about 3.8 million shares a day.
Similar companies
TVTX · EWTX · COGT · ADPT · DNTH · SRRK
Questions
What grade does Ionis Pharmaceuticals, Inc. (IONS) have?
In our weekly check, Ionis Pharmaceuticals, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 8 pass, warnings: 3, red flags: 11. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of IONS stock?
This week's biggest flags for Ionis Pharmaceuticals, Inc.: High debt, Weak interest cover, Margins falling. In total 14 of 22 checks show a warning or a red flag.
What does Ionis Pharmaceuticals, Inc. do?
Ionis Pharmaceuticals, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as IONS.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis